PharmAthene (PIP) Crumbles: Stock Falls by 7.1%
PharmAthene, Inc. (PIP) saw a big move last session, as the company’s shares fell by over 7% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This continues the recent downtrend for PIP, as the stock is now down over 29% in the past one-month time frame.
This biodefense company has seen a flat track record when it comes to current year estimate revisions over the past few weeks, and the consensus for earnings hasn’t been in a trend either. This recent price action is discouraging, so make sure to keep a close watch on this firm in the near future, and especially on earnings estimates following the recent slump.
PharmAthene currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.0%.
Some better-ranked stocks in the same sector include Astellas Pharma, Inc. (ALPMY), Grifols, S.A. (GRFS) and Cardiome Pharma Corp. (CRME). Astellas Pharma and Cardiome Pharma carry a Zacks Rank #2 (Buy) while Grifols carries Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
PHARMATHENE INC (PIP): Free Stock Analysis Report
ASTELLAS PHARMA INC (ALPMY): Free Stock Analysis Report
CARDIOME PHARMA CORP ORD (CRME): Free Stock Analysis Report
GRIFOLS SA ADS (GRFS): Free Stock Analysis Report
Zacks Investment Research
